Cargando...
miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer
BACKGROUND: Breast cancer is the most common cancer among women worldwide, and approximately 70% of breast cancers are hormone receptor-positive and express estrogen receptor-α (ERα) or/and progesterone receptor. Therapies targeting ERα have been successfully used in patients with ERα(+) breast canc...
Gardado en:
| Publicado en: | J Exp Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6339391/ https://ncbi.nlm.nih.gov/pubmed/30658681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1039-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|